PT1146872E - Utilizacao de antagonistas do receptor de angiotensina ii para tratamento de enfarte agudo do miocardio. - Google Patents
Utilizacao de antagonistas do receptor de angiotensina ii para tratamento de enfarte agudo do miocardio.Info
- Publication number
- PT1146872E PT1146872E PT00902628T PT00902628T PT1146872E PT 1146872 E PT1146872 E PT 1146872E PT 00902628 T PT00902628 T PT 00902628T PT 00902628 T PT00902628 T PT 00902628T PT 1146872 E PT1146872 E PT 1146872E
- Authority
- PT
- Portugal
- Prior art keywords
- angiotensin
- treatment
- fist
- utilization
- receptor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99810061 | 1999-01-26 | ||
US46866499A | 1999-12-21 | 1999-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1146872E true PT1146872E (pt) | 2006-10-31 |
Family
ID=26153740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00902628T PT1146872E (pt) | 1999-01-26 | 2000-01-24 | Utilizacao de antagonistas do receptor de angiotensina ii para tratamento de enfarte agudo do miocardio. |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP1146872B1 (pt) |
JP (1) | JP2002535367A (pt) |
KR (1) | KR100674053B1 (pt) |
CN (1) | CN1337879A (pt) |
AT (1) | ATE330599T1 (pt) |
AU (1) | AU766453C (pt) |
BR (1) | BR0007686A (pt) |
CA (1) | CA2360691A1 (pt) |
CY (1) | CY1105257T1 (pt) |
CZ (1) | CZ20012682A3 (pt) |
DE (1) | DE60028928T2 (pt) |
DK (1) | DK1146872T3 (pt) |
ES (1) | ES2265910T3 (pt) |
HK (1) | HK1041808B (pt) |
HU (1) | HUP0105199A3 (pt) |
ID (1) | ID29818A (pt) |
IL (2) | IL144216A0 (pt) |
NO (1) | NO20013459L (pt) |
NZ (1) | NZ513039A (pt) |
PL (1) | PL197161B1 (pt) |
PT (1) | PT1146872E (pt) |
RU (2) | RU2298405C2 (pt) |
SI (1) | SI1146872T1 (pt) |
SK (1) | SK10522001A3 (pt) |
WO (1) | WO2000044378A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038676A1 (en) * | 1998-12-23 | 2000-07-06 | Novartis Ag | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
EP1314425A4 (en) * | 2000-08-30 | 2004-06-02 | Sankyo Co | MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE |
US7076287B2 (en) | 2000-12-29 | 2006-07-11 | Ge Medical Systems Information Technologies, Inc. | System and method for detecting new left bundle branch block for accelerating treatment of acute myocardial infarction |
EP1448190A2 (en) * | 2001-10-18 | 2004-08-25 | Novartis AG | Salts formed of an at1-receptor antagonist and a cardiovascular agent |
EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
PL373202A1 (en) * | 2002-05-17 | 2005-08-22 | Novartis Ag | Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction |
SE0302331D0 (sv) * | 2003-08-29 | 2003-08-29 | Astrazeneca Ab | New use II |
WO2005030202A1 (en) * | 2003-09-26 | 2005-04-07 | Novartis Ag | Use of angiotensin ii receptor antagonists for treating cerebrovascular disorders |
WO2005053687A1 (en) * | 2003-11-25 | 2005-06-16 | Novartis Ag | Combination of organic compounds |
WO2009087116A1 (en) * | 2008-01-11 | 2009-07-16 | Novartis Ag | Use of spp100 for the treatment of acute mi |
CN104086623B (zh) * | 2014-07-02 | 2017-05-24 | 牡丹江友搏药业有限责任公司 | 一种新的具有降压和细胞保护作用的化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9027208D0 (en) * | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
EP0577025A3 (de) * | 1992-07-01 | 1998-02-04 | Hoechst Aktiengesellschaft | Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen |
FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US5795904A (en) * | 1996-12-06 | 1998-08-18 | Merck & Co., Inc. | Enhanced functional recovery of the heart by losartan treatment after an ischemic attach |
-
2000
- 2000-01-24 CA CA002360691A patent/CA2360691A1/en not_active Abandoned
- 2000-01-24 CN CN00803157A patent/CN1337879A/zh active Pending
- 2000-01-24 WO PCT/EP2000/000525 patent/WO2000044378A1/en active Application Filing
- 2000-01-24 JP JP2000595681A patent/JP2002535367A/ja not_active Withdrawn
- 2000-01-24 DE DE60028928T patent/DE60028928T2/de not_active Revoked
- 2000-01-24 AT AT00902628T patent/ATE330599T1/de not_active IP Right Cessation
- 2000-01-24 ES ES00902628T patent/ES2265910T3/es not_active Expired - Lifetime
- 2000-01-24 NZ NZ513039A patent/NZ513039A/en unknown
- 2000-01-24 CZ CZ20012682A patent/CZ20012682A3/cs unknown
- 2000-01-24 AU AU24397/00A patent/AU766453C/en not_active Ceased
- 2000-01-24 PL PL349537A patent/PL197161B1/pl not_active IP Right Cessation
- 2000-01-24 SI SI200030891T patent/SI1146872T1/sl unknown
- 2000-01-24 KR KR1020017009327A patent/KR100674053B1/ko not_active IP Right Cessation
- 2000-01-24 EP EP00902628A patent/EP1146872B1/en not_active Revoked
- 2000-01-24 DK DK00902628T patent/DK1146872T3/da active
- 2000-01-24 RU RU2001122113/15A patent/RU2298405C2/ru not_active IP Right Cessation
- 2000-01-24 IL IL14421600A patent/IL144216A0/xx active IP Right Grant
- 2000-01-24 EP EP06009525A patent/EP1714651A1/en not_active Withdrawn
- 2000-01-24 BR BR0007686-4A patent/BR0007686A/pt not_active Application Discontinuation
- 2000-01-24 ID IDW00200101602A patent/ID29818A/id unknown
- 2000-01-24 HU HU0105199A patent/HUP0105199A3/hu unknown
- 2000-01-24 PT PT00902628T patent/PT1146872E/pt unknown
- 2000-01-24 SK SK1052-2001A patent/SK10522001A3/sk not_active Application Discontinuation
-
2001
- 2001-07-09 IL IL144216A patent/IL144216A/en not_active IP Right Cessation
- 2001-07-12 NO NO20013459A patent/NO20013459L/no not_active Application Discontinuation
-
2002
- 2002-02-22 HK HK02101372.4A patent/HK1041808B/zh not_active IP Right Cessation
-
2006
- 2006-09-07 CY CY20061101283T patent/CY1105257T1/el unknown
- 2006-10-05 RU RU2006135205/15A patent/RU2345790C2/ru not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105257T1 (el) | Χρηση των ανταγωνιστων των υποδοχεων της αγγειοτενσινης ii στην θepαπεια του οξεος εμφραγματος του μυοκαρδιου | |
BR0110079A (pt) | Combinação de compostos orgânicos | |
ES2091877T3 (es) | Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia. | |
CY1106697T1 (el) | Ν-υποκατεστημενες υδρομορφονες και η χρηση αυτων | |
BRPI0412557A (pt) | forma de dosagem farmacêutica de eventos cardiovasculares | |
DK1588706T3 (da) | Valsartantablet | |
NO963064D0 (no) | Behandling av normotensive glaukoma med angiotensin-II-antagonister | |
HUP0202734A3 (en) | Use of pegylated interfron alfa-ccr5 antagonist combination for hiv therapy | |
BR9813214A (pt) | Antagonista de receptor vitronectina | |
IL132853A0 (en) | Combination therapy for modulating the human sexual response | |
IL206566A0 (en) | Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide | |
EA200100089A1 (ru) | Предотвращение рецидива мигрени | |
IL145645A0 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists | |
EA200601592A1 (ru) | Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора | |
CY1105302T1 (el) | Μη-πεπτιδιο ανταγωνιστες υποδοχεα ccr1 για την θepαπεια προϊουσης νεφρικης ινωσης | |
MY135441A (en) | Therapeutic treatment | |
BR0000486A (pt) | Antagonistas do neuropeptìdeo y | |
PT896822E (pt) | 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y | |
WO2000076500A8 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
WO2000007544A3 (en) | Vitronectin receptor antagonists | |
WO2000076457A3 (en) | Il-8 receptor antagonists | |
EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
TR200200111T2 (tr) | Neoplazmalar için terapötik ve profilaktik maddeler | |
NO981188D0 (no) | 5-HT3-reseptorantagonister for dyskinesi |